Natasha Girgis

Company: Cue Biopharma

Job title: Director, Translational Pharmacology

Seminars:

Exploring CUE-401: A Novel TGF-β/ IL-2 Fusion Protein for the Induction & Expansion of FOXP3+ Regulatory T-Cells 11:30 am

TGF-β and IL-2 are two key signals for the induction of regulatory T-cell populations CUE-401 is a novel TGF-β and IL-2 directed therapy that is being developed for the selective expansion of regulatory T-cells in vivo Exploring the activity and mechanism of action of CUE-401Read more

day: Day 2 Treg Modulators Track AM